How Can We Unlock the Next Wave of GPCR Therapeutics?

 

As the industry looks beyond GLP-1 therapeutics to identify the next breakthrough opportunity, researchers are accelerating the discovery of novel GPCR targets through advances in AI-enabled drug discovery, GPCR structural biology, cryo-EM, structure-guided drug design, next-generation screening technologies, and GPCR signaling biology. Yet significant challenges remain, from advancing orphan GPCR drug discovery and GPCR target validation to translating complex receptor biology into first-in-class and best-in-class therapeutics.

The 6th GPCR-Targeted Drug Discovery Summit brings together the scientists, innovators, and drug developers leading the future of GPCR drug discovery to:
  • Unlock novel GPCR biology through advances in orphan GPCRs, deorphanization, receptor biology, target validation, and the identification of emerging GPCR targets.
  • Accelerate GPCR-targeted drug discovery with AI for GPCR drug discovery, machine learning approaches, structure-based drug design (SBDD), advanced screening platforms, DNA-encoded library screening, and translational pharmacology strategies.
  • Explore next-generation GPCR therapeutics across small molecules, antibodies, biologics, peptides, ADCs, and multi-receptor therapeutics targeting obesity, oncology, CNS, immunology, autoimmune diseases, inflammation, and pain.
Join a dedicated community of GPCR researchers and biopharma leaders shaping the next GPCR success story and defining the future of GPCR drug discovery. Leave equipped with the insights, partnerships, and strategies needed to accelerate your next breakthrough therapeutic.
Round Tables Conference

What To Expect?

Go Beyond GLP-1 to Identify the Next GPCR Breakthrough

Discover where the industry's next major scientific and commercial opportunities are emerging across novel targets, transformative technologies, and next-generation therapeutics.

Featuring Insights from:

Eli Lilly
Atrogi Logo
Kainova Therapeutics
Evaluate What AI & ML Has Actually Delivered for GPCR Discovery

Move beyond AI hype and benchmark how leading organizations are leveraging machine learning and computational approaches to improve discovery outcomes, candidate quality, and decision-making.

Featuring insights from:

Biagon Inc. Logo
LEMBAS Logo
Recursion Pharmaceuticals Logo
Unlock the Next Generation of GPCR Targets

Explore emerging approaches to orphan receptor discovery, target validation, super-dark GPCR biology, and signaling science to expand the future landscape of druggable receptors.

Featuring insights from:

University of Miami Logo
Duke University Logo
Advance Emerging Modalities Beyond Traditional Small Molecules

Compare the latest progress in antibodies, peptides, biologics, and multi-receptor therapeutics to determine the optimal modality for future GPCR programs.

Featuring insights from:

Confo Therapeutics
Abalone Bio Logo
SelekTx Precision Biologics Logo

Explore the Full Event Guide

  • Explore the complete 2027 agenda, featuring a dedicated focus day deep dive into emerging discovery technologies alongside two days of cutting-edge GPCR science.
  • Preview exclusive sessions from Eli Lilly, Pfizer, Roche, Recursion Pharmaceuticals, Alphamol, and University of Miami.
  • Discover how the industry is tackling GPCR discovery's biggest challenges, from target validation and signaling biology to AI accountability and biased agonism.
  • See who you'll be networking with, including scientific decision-makers from leading pharma, biotech, and academic organizations.
  • Identify the sessions, speakers, and networking opportunities most relevant to your programs before you attend.
Brochure Cover

Attending Companies Include

explore the agenda
Explore the Agenda

Discover the latest advances in AI-enabled discovery, target validation, signaling biology, and emerging GPCR therapeutics across three days of scientific discussion.  

Join Biopharma Experts
Partner With Us

Showcase your expertise to a highly targeted audience of scientists and decision-makers actively seeking technologies, services, and partners to accelerate GPCR discovery.

Partner With Us
Join the GPCR Community

Connect with leading pharma, biotech, and academic experts tackling the biggest challenges and opportunities shaping the future of GPCR drug discovery.